Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation |
---|---|---|---|---|
09:00-09:15 | 09:00-09:15 |
Optimal Management Strategy for T2DM Patients with ASCVD |
Yihong Sun | China-Japan Friendship Hospital |
09:15-09:22 | 09:15-09:22 |
Discussion |
||
09:22-09:37 | 09:22-09:37 |
Does GLP-1RA Have Class Effect in ASCVD Prevention? |
Jiangli Han | Peking University Third Hospital |
09:37-09:44 | 09:37-09:44 |
Discussion |
||
09:44-09:59 | 09:44-09:59 |
Comparison between DAPA-HF and EMPEROR-HF Trial |
baoxia chen | Peking University Third Hospital |
09:59-10:06 | 09:59-10:06 |
Discussion |
||
10:06-10:21 | 10:06-10:21 |
Insights from CREDANCE Trial and DAPA-CKD Trial |
Xiaoyan Xing | China-Japan Friendship Hospital |
10:21-10:30 | 10:21-10:30 |
Discussion |